Analysts’ Updated EPS Estimation for March, 27th (AME, AMID, AU, BAESY, BATRK, BDREF, BGNE, BP, BR, CFFN)

Analysts’ Updated EPS Estimation for March, 27th (AME, AMID, AU, BAESY, BATRK, BDREF, BGNE, BP, BR, CFFN)

Analysts’ updated eps estimates for Monday, March 27th:

AMETEK (NYSE:AME) had its buy rating reissued by analysts at BMO Capital Markets. The firm currently has a $65.00 price target on the stock.

American Midstream Partners (NYSE:AMID) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “American Midstream Partners, LP owns, operates, develops and acquire a diversified portfolio of natural gas midstream energy assets. The Company is engaged in the business of gathering, treating, processing and transporting natural gas through its ownership and operation of gathering systems, processing facilities and pipelines. Its primary assets, which are located in Alabama, Louisiana, Mississippi, Tennessee and Texas, provide infrastructure that links producers and suppliers of natural gas to diverse natural gas markets, including various pipelines, as well as utility, industrial and other commercial customers. American Midstream Partners, LP is based in Denver, Colorado. “

AngloGold Ashanti Limited (NYSE:AU) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “AngloGold Limited is the largest gold producer at 7 million ounces a year, with reserves of 126 m oz. The company has operations in six countries on three continents, some of which are joint ventures, as well as exploration activities in ten countries. AngloGold can be financially characterized by high cash generation, substantial reinvestment in long-term growth and the payment of significant dividends. The company distinguishes itself from its producer peer group through its active involvement in the development of the gold market, particularly in Asia. “

BAE Systems PLC (OTCMKTS:BAESY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “BAE Systems is a global company engaged in the development, delivery and support of advanced defence and aerospace systems in the air, on land and at sea. BAE Systems Inc. is the US subsidiary of BAE Systems plc. Headquartered in Rockville,Maryland, BAE Systems Inc. consists of three Operating Groups that provide support and service solutions for current and future defense, intelligence, and civilian systems; design, develop and manufacture a wide range of electronic systems and subsystems for both military and commercial applications; and design, develop, produce,and provide service support of armored combat vehicles, artillery systems and intelligent munitions. “

Liberty Braves Group (NASDAQ:BATRK) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Liberty Braves Group owns and operates Atlanta Braves Major League Baseball club, stadium and associated real estate projects. Liberty Braves Group is based in the United States. “

Beadell Resources (NASDAQ:BDREF) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Beadell Resources Limited is a gold producer. It owns and operates the Tucano gold mine primarily in Brazil. Beadell Resources Limited is based in West Perth, Australia. “

Beigene (NASDAQ:BGNE) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company’s clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands. “

BP plc (NYSE:BP) had its buy rating reaffirmed by analysts at Scotiabank. They currently have a $38.00 target price on the stock.

Broadridge Financial Solutions (NYSE:BR) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Broadridge is a leading global provider of technology-based outsourcing solutions to the financial services industry. Their integrated systems and services include investor communication, securities processing, and clearing and outsourcing solutions. Broadridge offers a broad, integrated suite of innovative global solutions across the investment lifecycle and provides a wide range of cost-effective and scalable solutions to the financial industry. Their systems help reduce the need for clients to make significant capital investments in operations infrastructure, thereby allowing them to increase their focus on core business activities. “

Capitol Federal Financial (NASDAQ:CFFN) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Capitol Federal Financial is a federally chartered mid-tier holding company. Capitol Federal Savings Bank is the only operating subsidiary. The bank is a community-oriented financial institution offering a variety of financial services to meet the needs of the communities we serve. They attract retail deposits from the general public and invest those funds primarily in permanent loans secured by first mortgages on owner-occupied, one- to four-family residences. “

Colony NorthStar (NYSE:CLNS) was downgraded by analysts at Zacks Investment Research from a buy rating to a strong sell rating. According to Zacks, “Colony NorthStar, Inc. is a real estate and investment management firm. It creates long-term value through investing in real estate and real estate-related assets. Colony NorthStar Inc., formerly known as Northstar Asset management Group, is based in New York. “

Clearside Biomedical (NASDAQ:CLSD) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space(TM) microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. Clearside Biomedical, Inc. is headquartered in Alpharetta, Georgia. “

Columbia Property Trust (NYSE:CXP) was upgraded by analysts at Evercore ISI to an outperform rating.

Corecivic (NYSE:CXW) had its buy rating reaffirmed by analysts at Canaccord Genuity. They currently have a $34.00 price target on the stock.

Deltic Timber Corp (NYSE:DEL) had its equal weight rating reissued by analysts at Morgan Stanley. Morgan Stanley currently has a $45.00 target price on the stock.

Goldman Sachs Group Inc began coverage on shares of DXC Technology Company (NYSE:DXC). They issued a buy rating on the stock.

eBay (NASDAQ:EBAY) had its hold rating reiterated by analysts at BMO Capital Markets. They currently have a $33.00 target price on the stock.

Eclipse Resources Corp (NYSE:ECR) had its hold rating reissued by analysts at Scotiabank. Scotiabank currently has a $3.50 target price on the stock.

Energen (NYSE:EGN) had its buy rating reissued by analysts at Scotiabank. Scotiabank currently has a $64.00 price target on the stock.

EP Energy Corp (NYSE:EPE) had its hold rating reissued by analysts at Scotiabank. Scotiabank currently has a $4.00 price target on the stock.

Diamondback Energy (NASDAQ:FANG) had its buy rating reiterated by analysts at Scotiabank. The firm currently has a $121.00 target price on the stock.

Fidelity National Information Servcs (NYSE:FIS) was downgraded by analysts at Goldman Sachs Group Inc from a buy rating to a neutral rating.

The GEO Group (NYSE:GEO) had its buy rating reiterated by analysts at Canaccord Genuity. They currently have a $50.00 price target on the stock.

Gulfport Energy (NASDAQ:GPOR) had its buy rating reaffirmed by analysts at Scotiabank. They currently have a $29.00 price target on the stock.

Halcon Resources (NYSE:HK) had its buy rating reaffirmed by analysts at Scotiabank. Scotiabank currently has a $11.00 target price on the stock.

IDEX (NYSE:IEX) had its hold rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a $101.00 target price on the stock.

Nordstrom (NYSE:JWN) had its hold rating reaffirmed by analysts at BMO Capital Markets. They currently have a $50.00 target price on the stock.

The Coca-Cola (NYSE:KO) had its market perform rating reaffirmed by analysts at Wells Fargo & Co.

Kohl's Co. (NYSE:KSS) had its hold rating reiterated by analysts at BMO Capital Markets. The firm currently has a $45.00 target price on the stock.

PBF Energy (NYSE:PBF) had its buy rating reissued by analysts at Scotiabank. Scotiabank currently has a $24.00 target price on the stock.

Penumbra (NYSE:PEN) had its buy rating reiterated by analysts at Canaccord Genuity. They currently have a $91.00 price target on the stock.

Phillips 66 (NYSE:PSX) had its hold rating reaffirmed by analysts at Scotiabank. They currently have a $86.00 target price on the stock.

SeaWorld Entertainment (NYSE:SEAS) had its buy rating reissued by analysts at FBR & Co.

Silgan Holdings (NASDAQ:SLGN) had its buy rating reiterated by analysts at BMO Capital Markets. They currently have a $65.00 target price on the stock.

SM Energy (NYSE:SM) had its buy rating reaffirmed by analysts at Scotiabank. The firm currently has a $33.00 target price on the stock.

Tesoro (NYSE:TSO) had its buy rating reiterated by analysts at Scotiabank. They currently have a $91.00 price target on the stock.

Valero Energy (NYSE:VLO) had its buy rating reaffirmed by analysts at Scotiabank. Scotiabank currently has a $70.00 target price on the stock.

Viper Energy Partners (NASDAQ:VNOM) had its hold rating reissued by analysts at Scotiabank. They currently have a $20.00 target price on the stock.

WPX Energy (NYSE:WPX) had its buy rating reissued by analysts at Scotiabank. The firm currently has a $20.00 target price on the stock.

Wildhorse Resource Development Corp (NYSE:WRD) had its buy rating reaffirmed by analysts at Scotiabank. Scotiabank currently has a $20.00 target price on the stock.

Related posts

Leave a Comment